Carlyle Group Entities Report Over $1 Billion Sale of Medline Shares
MDLN is trading near its 52-week low of $38 (8.1% above the low).
Summary
Major 10% owner Carlyle Group entities sold over $1 billion in Medline Inc. shares as part of a previously announced secondary offering.
Key Events · Ownership and Investor Activity · MDLN
-
Major Shareholder Sells Over $1 Billion in Stock
TC Group Cayman Investment Holdings, L.P., and affiliated Carlyle entities, disposed of 26,105,840 Class A common shares for $1,070,339,440.00.
-
Part of Previously Announced Secondary Offering
This sale on March 10, 2026, at $41.00 per share, is a component of the larger secondary offering by major private equity shareholders that was previously announced and closed.
-
Significant Reduction in Holdings
The transaction represents a substantial reduction in the Carlyle entities' ownership stake in Medline Inc.
Analysis · MDLN · Industrial Applications And Services
TC Group Cayman Investment Holdings, L.P., and related Carlyle entities, which are 10% owners of Medline Inc., reported the sale of 26,105,840 Class A common shares for approximately $1.07 billion. This transaction, executed on March 10, 2026, at a price of $41.00 per share, represents a significant reduction in their holdings and is part of the previously announced secondary offering by major private equity shareholders. While the overall secondary offering was already disclosed and closed, this Form 4 provides specific details of Carlyle's participation, indicating a continued monetization of their investment.
At the time of this filing, MDLN was trading at $41.07 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $54B. The 52-week trading range was $38.00 to $50.88. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.